Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ERK–CREB–BDNF pathway** is a core neuronal signaling cascade integrating extracellular stimuli through the activation of **ERK (extracellular signal-regulated kinase)**, which then phosphorylates and activates the transcription factor **CREB (cAMP response element-binding protein)**. Activated CREB upregulates transcription of neurotrophic genes, notably **BDNF (brain-derived neurotrophic factor)**. BDNF acts on its receptor (TrkB), further reinforcing this signaling loop and contributing to key processes in synaptic plasticity, cell survival, neurogenesis, and neuroprotection. Dysregulation of this pathway is implicated in a range of neurological and psychiatric diseases, including depression, neurodegenerative disorders, pain, and autism. Therapeutically, drugs that enhance or modulate the ERK–CREB–BDNF pathway show neuroprotective and antidepressant effects but require careful targeting due to potential oncogenic or excitatory side effects.
Activation or inhibition of ERK phosphorylation modulates CREB activity CREB phosphorylation alters transcription of neurotrophic genes such as BDNF Drugs enhancing this pathway (e.g., antidepressants, neurotrophic agonists) promote neuroprotection, synaptic plasticity, and antidepressant effects Inhibition may suppress pathological gene expression, e.g., in pain, epilepsy, addiction
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ERK–CREB–BDNF signaling pathway (null).